TAVO-421
N/A
Report date: 2024/06/17 10:08:21
Base Information
Drug NameTAVO-421
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTavotek Biotherapeutics
China Registration ClassN/A
Develop Information
Active CompaniesTavotek Biotherapeutics
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A